Dapsone therapy for hidradenitis suppurativa: A series of 24 patients

Dermatology

Volumn 222, Issue 4, 2011, Pages 342-346

  Yazdanyar, Shiva ^a,e   Boer, Jurr ^b   Ingvarsson, Gisli ^c   Szepietowski, Jacek C ^d   Jemec, Gregor B E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DEVENTER HOSPITAL   (Netherlands)

^c UNIVERSITY OF TROMSØ   (Norway)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e ROSKILDE HOSPITAL   (Denmark)

Author keywords

Dapsone therapy; Hidradenitis suppurativa, retrospective study

Indexed keywords

CIPROFLOXACIN; DAPSONE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; RIFAMPICIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; EXPLORATORY RESEARCH; FEMALE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SIDE EFFECT; SUPPURATIVE HIDRADENITIS;

ADULT; DAPSONE; DERMATOLOGIC AGENTS; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80052444765     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000329023     Document Type: Article

References (27)

1. Jemec GB: Hidradenitis suppurativa. J Cutan Med Surg 2003; 7: 47-56.
2. Jemec GB, Revuz J, Leyden J: Hidradenitis Suppurativa, ed 1. Berlin, Springer, 2006.
3. Revuz J: Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2009; 23: 985-998.
4. Jemec GB, Heidenheim M, Nielsen NH: The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35: 191-194.
5. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji- Garin S: Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies. J Am Acad Dermatol 2008; 59: 596-601.
6. Der Werth JM, Jemec GB: Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809-813. (Pubitemid 32374785)
7. Esmann S, Dufour DN, Jemec GB: Questionnaire- based diagnosis of hidradenitis suppurativa: Specificity, sensitivity and positive predictive value of specific diagnostic questions. Br J Dermatol 2010; 163: 102-106.
8. Jemec GB, Heidenheim M, Nielsen NH: Hidradenitis suppurativa - characteristics and consequences. Clin Exp Dermatol 1996; 21: 419-423. (Pubitemid 27198665)
9. Matusiak L, Bieniek A, Szepietowski JC: Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010; 90: 264-268.
10. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J: Quality of life impairment in hidradenitis suppurativa: A study of 61 cases. J Am Acad Dermatol 2007; 56: 621-623. (Pubitemid 46400178)
11. Adams DR, Yankura JA, Fogelberg AC, Anderson BE: Treatment of hidradenitis suppurativa with etanercept injection. Arch Dermatol 2010; 146: 501-504.
12. Clemmensen OJ: Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983; 22: 325-328. (Pubitemid 13107515)
13. Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA: Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, doubleblind, placebo-controlled crossover trial. J Am Acad Dermatol 2010; 62: 205-217.
14. Jemec GB, Wendelboe P: Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971-974. (Pubitemid 28547731)
15. Mortimer PS, Dawber RP, Gales MA, Moore RA: A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986; 115: 263-268. (Pubitemid 16055913)
16. Hofer T, Itin PH: Acne inversa: A dapsonesensitive dermatosis (in German). Hautarzt 2001; 52: 989-992.
17. Kaur MR, Lewis HM: Hidradenitis suppurativa treated with dapsone: A case series of five patients. J Dermatolog Treat 2006; 17: 211-213. (Pubitemid 44395545)
18. Lang PG Jr: Sulfones and sulfonamides in dermatology today. J Am Acad Dermatol 1979; 1: 479-492.
19. Boer J, Weltevreden EF: Hidradenitis suppurativa or acne inversa: A clinicopathological study of early lesions. Br J Dermatol 1996; 135: 721-725. (Pubitemid 26375888)
20. Jemec GB, Hansen U: Histology of hidradenitis suppurativa. J Am Acad Dermatol 1996; 34: 994-999. (Pubitemid 26170764)
21. Jemec GB, Thomsen BM, Hansen U: The homogeneity of hidradenitis suppurativa lesions: A histological study of intra-individual variation. APMIS 1997; 105: 378-383. (Pubitemid 27229648)
22. Kamp S, Fiehn AM, Stenderup K, Rosada C, Pakkenberg B, Kemp K, Dam TN, Jemec GB: Sebaceous gland number and volume is significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol 2011; 164: 1017-1022.
23. Haslund P, Lee RA, Jemec GB: Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 2009; 89: 595-600.
24. Kimball A, Jemec G, Okun M, Gu Y: Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: Results from the placebo-controlled portion of a phase II, randomized, double-blind study. J Am Acad Dermatol 2011; 64(suppl 1):AB155.
25. Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB: A double blind placebo controlled randomised trial of adalimumab in the treatment of hidradenitis suppurativa. Br J Dermatol 2011, E-pub ahead of print.
26. Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Garin S: Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: A series of 116 consecutive patients. Dermatology 2009; 219: 148-154.
27. Van Der Zee HH, Boer J, Prens EP, Jemec GB: The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009; 219: 143-147.